KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lam Research (LRCX) Other Non-Current Liabilities (2016 - 2026)

Lam Research has reported Other Non-Current Liabilities over the past 17 years, most recently at $621.6 million for Q1 2026.

  • For Q1 2026, Other Non-Current Liabilities fell 10.0% year-over-year to $621.6 million; the TTM value through Mar 2026 reached $621.6 million, down 10.0%, while the annual FY2025 figure was $581.6 million, 1.15% up from the prior year.
  • Other Non-Current Liabilities for Q1 2026 was $621.6 million at Lam Research, down from $667.6 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $931.1 million in Q2 2022 and troughed at $496.4 million in Q4 2022.
  • A 5-year average of $686.5 million and a median of $667.6 million in 2025 define the central range for Other Non-Current Liabilities.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 140.28% in 2022 and later plummeted 46.16% in 2023.
  • Year by year, Other Non-Current Liabilities stood at $496.4 million in 2022, then skyrocketed by 60.68% to $797.6 million in 2023, then decreased by 16.03% to $669.7 million in 2024, then fell by 0.31% to $667.6 million in 2025, then decreased by 6.9% to $621.6 million in 2026.
  • Business Quant data shows Other Non-Current Liabilities for LRCX at $621.6 million in Q1 2026, $667.6 million in Q4 2025, and $623.9 million in Q3 2025.